Navigation Links
WaferGen Announces Management Team Promotions
Date:3/3/2008

National Institutes of Health (NIH).

To learn more about WaferGen, please visit the company's web site at http://www.wafergen.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such statements include statements containing words such as "likely" or "expects" and words of similar import or statements of management's opinion. For such statements, the company claims the protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the company. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that: (i) the company may be unsuccessful in commercially developing its products or in achieving market acceptance of new and relatively unproven technologies; (ii) the company will need to raise additional capital to meet its business requirements in the future and the company may not be able to do so on reasonable terms or at all; (iii) the company's proprietary intellectual property rights may not adequately protect its products and technologies; and (iv) the company expects intense competition in its target markets, including from companies that have much greater resources than the company, and there can be no assurance that the company will be able to compete effectively. More detailed information about the company and the risk factors that may affect the realization of forward-looking statements is set forth in the company's filings with the Securities and Exchange Commission, including the co
'/>"/>

SOURCE WaferGen Biosystems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
2. WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
4. BioWa Announces Expansion of License Agreement with Genentech for BioWas POTELLIGENT(R) Technology
5. DW Healthcare Partners Announces the Sale of Tandem Labs
6. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
7. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
8. MarketResearch.com Announces Distribution of Spectra Intelligence Research
9. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
10. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
11. Wyeth Announces Executive Change in Finance Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Windsor, CT (PRWEB) , ... July 29, 2015 ... ... of Biological Industries’ (BI) advanced cell culture products, announces the availability of BI’s ... Recently launched by Biological Industries, these stem cell differentiation media offer a complete ...
(Date:7/28/2015)... , ... July 29, 2015 , ... The new Xsample 530 sample changer for ... a wide range of liquid viscosities – from less than 12,000 mPas (internal air) up ... vials. , What immediately catches the eye about Xsample 530 is its removable magazine, ...
(Date:7/28/2015)... Research and Markets ... the "Analysis of the Global Flow Cytometry ... Globally, flow cytometry remains a popular tool ... and stem cells. But the market is witnessing ... demand from underdeveloped nations to quantitate CD4 cell ...
(Date:7/28/2015)... July 28, 2015  Kerastem Technologies announce that the ... U.S. FDA Center For Biologics Evaluation and Research (CBER) ... a clinical trial investigating the safety and feasibility of ... early male pattern baldness (androgenic alopecia). The ... initial clinical work in Europe ...
Breaking Biology Technology:Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2
... back all the hype, all the emotional arguments, and all ... getting? , ,In the great race for global competitiveness, economic ... fuel for broadband connectivity is the need for speed. Thats ... politicians need to know. , , AT&T's Project ...
... Wis. - A California-based life sciences company with ... handle the most studied class of proteins in today's ... made possible by Invitrogen Corp. 's recent acquisition ... Invitrogen's Discovery Sciences Business in Madison. , , The ...
... million Wisconsin credit union members are conceivable targets of a ... financial institutions via e-mail. , ,According to a notice from ... for more than 270 credit unions in the state, several ... questionnaire prompting them to take part in a five-question survey ...
Cached Biology Technology:Broadband blues: Don't fall for Lightspeed hype 2Broadband blues: Don't fall for Lightspeed hype 3Broadband blues: Don't fall for Lightspeed hype 4Broadband blues: Don't fall for Lightspeed hype 5Invitrogen boosts drug development capability 2Online scam targets credit union members 2
(Date:7/21/2015)... , July 21, 2015 Passwords have ... seen in the recent U.S. Office of Personnel ... to the infosec conundrum, but developers and end-users ... To address this dilemma, Biometrics-as-a-Service provider HYPR Corp. ... Tokenization SDK for third party integration. ...
(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs ... announcing its acquisition of Avid Nano. Avid Nano ... scattering (DLS) systems.    Also today, ... fastest and easiest to use protein sizing system. ... measures a protein,s hydrodynamic size, size distribution, aggregation ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... [Brown University] It,s been long known that asbestos spells ... spiky, long asbestos fibers, and the image is gory: Part ... quivering arrow that,s found its mark. But scientists had ... asbestos fibers and other materials at the nanoscale that are ...
... solved the structure of a retrovirus enzyme whose configuration ... The gamers achieved their discovery by playing Foldit, an ... in predicting the structure of protein molecules. After ... a protein-cutting enzyme from an AIDS-like virus, they called ...
... LA JOLLA, CA -- A "hidden" code linked to the ... new biological traits far more rapidly than previously thought, according ... the Salk Institute for Biological Studies. The study, published ... evidence that an organism,s "epigenetic" code - an extra layer ...
Cached Biology News:Why carbon nanotubes spell trouble for cells 2Gamers succeed where scientists fail 2Gamers succeed where scientists fail 3Are genes our destiny? 2Are genes our destiny? 3Are genes our destiny? 4
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... vitro diagnostic assays, all EIA/RIA plates are ... binding, high optical clarity and low background ... of the Certified Surface Chemistry Programme, which ... QA release specifications. Linkage: This CLS number ...
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
... The lyophilization stabilizer is designed to ... and for long-term storage. There ... ingredients. It is a convenient ... 7.2, and is superior to other ...
Biology Products: